Related references
Note: Only part of the references are listed.Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
John F. de Groot et al.
CLINICAL CANCER RESEARCH (2011)
Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in Amyotrophic Lateral Sclerosis (ALS) patients
Pawan K. Gupta et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Camel nanoantibody is an efficient tool for research, diagnostics and therapy
S. V. Tillib
MOLECULAR BIOLOGY (2011)
Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLC
Eloisa Jantus-Lewintre et al.
LUNG CANCER (2011)
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer
Athanassios Argiris et al.
ORAL ONCOLOGY (2011)
Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer
Ayman Eldesoky et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2011)
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu et al.
CURRENT DRUG TARGETS (2010)
Current Molecular Understanding and Future Treatment Strategies for Pathologic Ocular Neovascularization
Michael J. Tolentino
CURRENT MOLECULAR MEDICINE (2009)
Adverse effects of anticancer agents that target the VEGF pathway
Helen X. Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
Janusz Wesolowski et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Camelid immunoglobulins and nanobody technology
S. Muyldermans et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
Sergey M. Deyev et al.
BIOESSAYS (2008)
Single-domain antibodies as building blocks for novel therapeutics
Dirk Saerens et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Targeting and tracing antigens in live cells with fluorescent nanobodies
Ulrich Rothbauer et al.
NATURE METHODS (2006)
Formatted anti-tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
Ken Coppieters et al.
ARTHRITIS AND RHEUMATISM (2006)
β-lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae
KE Conrath et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
